Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
Editor’s note: This is a developing news story. Please check back soon for updates.
Alcon and STAAR Surgical terminated their definitive merger agreement.
According to a press release from STAAR, preliminary estimates showed that the company did not receive the necessary stockholder votes to approve the merger agreement during a special meeting of stockholders on Jan. 6.
“The board approved the Alcon agreement because we determined that it was in the best interests of STAAR stockholders,” Stephen Farrell, CEO of STAAR, said in the release. “We respect the outcome of the vote and look forward to